(Q40570652)

21 September 2017

A functional role for CD28 costimulation in tumor recognition by single-chain receptor-modified T cells (English)

1 reference

21 September 2017

9

1 reference

21 September 2017

10

1 reference

21 September 2017

Phillip K Darcy

11

0 references

Joseph A. Trapani

object named as

Joseph A Trapani

3

0 references

Stephen M Jane

object named as

Stephen M Jane

8

0 references

Anja Maria Möller

1

object named as

Maria Moeller

1 reference

21 September 2017

4

Michele W L Teng

1 reference

21 September 2017

5

Jacob T Jackson

1 reference

21 September 2017

7

Loretta Cerutti

1 reference

21 September 2017

Nicole M Haynes

2

1 reference

PubMed ID

15060573

21 September 2017

Jane E Tanner

6

1 reference

21 September 2017

1 May 2004

1 reference

21 September 2017

1 reference

21 September 2017

11

1 reference

21 September 2017

371-379

1 reference

21 September 2017

5

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.cgt.7700710

21 September 2017

0 references

cites work

Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700710

Melanocyte destruction after antigen-specific immunotherapy of melanoma: direct evidence of t cell-mediated vitiligo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700710

A phase I study of nonmyeloablative chemotherapy and adoptive transfer of autologous tumor antigen-specific T lymphocytes in patients with metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700710

Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma: in vivo persistence, migration, and antitumor effect of transferred T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700710

Clinical effects and toxicity of interleukin-2 in patients with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700710

Natural history of HLA expression during tumour development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700710

Can co-stimulated tumor immunity be therapeutically efficacious?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700710

Cytotoxic T lymphocytes with a grafted recognition specificity for ERBB2-expressing tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700710

Expression in cytotoxic T lymphocytes of a single-chain anti-carcinoembryonic antigen antibody. Redirected Fas ligand-mediated lysis of colon carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700710

Redirecting mouse CTL against colon carcinoma: superior signaling efficacy of single-chain variable domain chimeras containing TCR-zeta vs Fc epsilon RI-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700710

Specific activation and targeting of cytotoxic lymphocytes through chimeric single chains consisting of antibody-binding domains and the gamma or zeta subunits of the immunoglobulin and T-cell receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700710

Fas-ligand-mediated lysis of erbB-2-expressing tumour cells by redirected cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700710

Sequence requirements for induction of cytolysis by the T cell antigen/Fc receptor zeta chain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700710

Single-chain antigen recognition receptors that costimulate potent rejection of established experimental tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700710

Human T-lymphocyte cytotoxicity and proliferation directed by a single chimeric TCRζ /CD28 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700710

Binding of phosphatidylinositol-3-OH kinase to CD28 is required for T-cell signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700710

The cytoplasmic domain of CD28 is both necessary and sufficient for costimulation of interleukin-2 secretion and association with phosphatidylinositol 3'-kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700710

Proline residues in CD28 and the Src homology (SH)3 domain of Lck are required for T cell costimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700710

Critical requirement for the membrane-proximal cytosolic tyrosine residue for CD28-mediated costimulation in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700710

A point mutation in CD28 distinguishes proliferative signals from survival signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700710

T-cell antigen CD28 interacts with the lipid kinase phosphatidylinositol 3-kinase by a cytoplasmic Tyr(P)-Met-Xaa-Met motif

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700710

Selective CD28pYMNM mutations implicate phosphatidylinositol 3-kinase in CD86-CD28-mediated costimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700710

Redirected Perforin-Dependent Lysis of Colon Carcinoma by Ex Vivo Genetically Engineered CTL

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700710

Rejection of Syngeneic Colon Carcinoma by CTLs Expressing Single-Chain Antibody Receptors Codelivering CD28 Costimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700710

Prospective randomized trial of high-dose interleukin-2 alone or in conjunction with lymphokine-activated killer cells for the treatment of patients with advanced cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700710

7 January 2021

Treatment of patients with metastatic melanoma with autologous tumor-infiltrating lymphocytes and interleukin 2

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700710

7 January 2021

Effects of interleukin-2 on renal function in patients receiving immunotherapy for advanced cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700710

7 January 2021

Functional expression of chimeric receptor genes in human T cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700710

7 January 2021

Tumor-specific T cell activation by recombinant immunoreceptors: CD3 zeta signaling and CD28 costimulation are simultaneously required for efficient IL-2 secretion and can be integrated into one combined CD28/CD3 zeta signaling receptor molecule

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700710

7 January 2021

CD4(+) T cells are required for the development of cytotoxic CD8(+) T cells during Mycobacterium tuberculosis infection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700710

7 January 2021

Identifiers

DOI

10.1038/SJ.CGT.7700710

1 reference

PubMed ID

15060573

Dimensions Publication ID

21 September 2017

0 references

1 reference

PubMed ID

15060573